Update on therapeutic management of idiopathic pulmonary fibrosis

References

• RaghuGCollardHREganJJAn official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and managementAm J Respir Crit Care Med2011183678882421471066
   PubMed Web of Science ®Google Scholar
• BjorakerJARyuJHEdwinMKPrognostic significance of histopathologic subsets in idiopathic pulmonary fibrosisAm J Respir Crit Care Med199815711992039445300
   PubMed Web of Science ®Google Scholar
• FlahertyKRToewsGBTravisWDClinical significance of histological classification of idiopathic interstitial pneumoniaEur Respir J200219227528311866008
   PubMed Web of Science ®Google Scholar
• NicholsonAGColbyTVdu BoisRMHansellDMWellsAUThe prognostic significance of the histologic pattern of interstitial pneumonia in patients presenting with the clinical entity of cryptogenic fibrosing alveolitisAm J Respir Crit Care Med200016262213221711112140
   PubMed Web of Science ®Google Scholar
• KingTEJrSchwarzMIBrownKIdiopathic pulmonary fibrosis: relationship between histopathologic features and mortalityAm J Respir Crit Care Med200116461025103211587991
   PubMed Web of Science ®Google Scholar
• TravisWDCostabelUHansellDMAn official American Thoracic Society/European Respiratory Society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumoniasAm J Respir Crit Care Med2013188673374824032382
   PubMed Web of Science ®Google Scholar
• LynchDATravisWDMüllerNLIdiopathic interstitial pneumonias: CT featuresRadiology20052361102115987960
   PubMed Web of Science ®Google Scholar
• KingTEJrPardoASelmanMIdiopathic pulmonary fibrosisLancet201137898071949196121719092
   PubMed Web of Science ®Google Scholar
• LeyBCollardHRKingTEJrClinical course and prediction of survival in idiopathic pulmonary fibrosisAm J Respir Crit Care Med2011183443144020935110
   PubMed Web of Science ®Google Scholar
• American Thoracic SocietyIdiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS)Am J Respir Crit Care Med20001612 Pt 164666410673212
   PubMed Web of Science ®Google Scholar
• SpagnoloPGrunewaldJdu BoisRMGenetic determinants of pulmonary fibrosis: evolving conceptsLancet Respir Med20142541642824815806
   PubMed Web of Science ®Google Scholar
• WoltersPJCollardHRJonesKDPathogenesis of idiopathic pulmonary fibrosisAnnu Rev Pathol2014915717924050627
   PubMed Web of Science ®Google Scholar
• SpagnoloPRossiGCavazzaAPathogenesis of idiopathic pulmonary fibrosis and its clinical implicationsExpert Rev Clin Immunol20141081005101724953006
   PubMed Web of Science ®Google Scholar
• MaherTMIdiopathic pulmonary fibrosis: pathobiology and novel approaches to treatmentClin Chest Med2012331698322365247
   PubMed Web of Science ®Google Scholar
• KingTEJrBradfordWZCastro-BernardiniSA phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosisN Engl J Med2014370222083209224836312
   PubMed Web of Science ®Google Scholar
• RicheldiLdu BoisRMRaghuGEfficacy and safety of nintedanib in idiopathic pulmonary fibrosisN Engl J Med2014370222071208224836310
   PubMed Web of Science ®Google Scholar
• AzumaANukiwaTTsuboiEDouble-blind, placebo-controlled trial of pirfenidone in patients with idiopathic pulmonary fibrosisAm J Respir Crit Care Med200517191040104715665326
   PubMed Web of Science ®Google Scholar
• TaniguchiHEbinaMKondohYPirfenidone in idiopathic pulmonary fibrosisEur Respir J201035482182919996196
   PubMed Web of Science ®Google Scholar
• NoblePWAlberaCBradfordWZPirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trialsLancet201137797791760176921571362
   PubMed Web of Science ®Google Scholar
• DanielsCELaskyJALimperAHImatinib treatment for IPF: randomised placebo controlled trial resultsAm J Respir Crit Care Med2010181660461020007927
   PubMed Web of Science ®Google Scholar
• RicheldiLCostabelUSelmanMEfficacy of a tyrosine kinase inhibitor in idiopathic pulmonary fibrosisN Engl J Med2011365121079108721992121
   PubMed Web of Science ®Google Scholar
• KuboHNakayamaKYanaiMAnticoagulant therapy for idiopathic pulmonary fibrosisChest200512831475148216162746
   PubMed Web of Science ®Google Scholar
• NothIAnstromKJCalvertSBA placebo-controlled randomized trial of warfarin in idiopathic pulmonary fibrosisAm J Respir Crit Care Med20121861889522561965
   PubMed Web of Science ®Google Scholar
• DemedtsMBehrJBuhlRHigh-dose acetylcysteine in idiopathic pulmonary fibrosisN Engl J Med2005353212229224216306520
   PubMed Web of Science ®Google Scholar
• Idiopathic Pulmonary Fibrosis Clinical Research NetworkMartinezFJde AndradeJAAnstromKJKingTEJrRaghuGPrednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosisN Engl J Med2012366211968197722607134
   PubMed Web of Science ®Google Scholar
• Idiopathic Pulmonary Fibrosis Clinical Research NetworkMartinezFJde AndradeJAAnstromKJKingTEJrRaghuGRandomized trial of acetylcysteine in idiopathic pulmonary fibrosisN Engl J Med2014370222093310124836309
   PubMed Web of Science ®Google Scholar
• ZiescheRHofbauerEWittmannKA preliminary study of long-term treatment with interferon gamma-1b and low-dose prednisolone in patients with idiopathic pulmonary fibrosisN Engl J Med1999341171264126910528036
   PubMed Web of Science ®Google Scholar
• RaghuGBrownKKBradfordWZA placebo-controlled trial of interferon gamma-1b in patients with idiopathic pulmonary fibrosisN Engl J Med2004350212513314711911
   PubMed Web of Science ®Google Scholar
• KingTEJrAlberaCBradfordWZEffect of interferon gamma-1b on survival in patients with idiopathic pulmonary fibrosis (INSPIRE): a multicentre, randomised, placebo-controlled trialLancet2009374968522222819570573
   PubMed Web of Science ®Google Scholar
• RaghuGBrownKKCostabelUTreatment of idiopathic pulmonary fibrosis with etanercept: an exploratory, placebo-controlled trialAm J Respir Crit Care Med2008178994895518669816
   PubMed Web of Science ®Google Scholar
• KingTEJrBehrJBrownKKBUILD-1: a randomized placebo-controlled trial of bosentan in idiopathic pulmonary fibrosisAm J Respir Crit Care Med20081771758117901413
   PubMed Web of Science ®Google Scholar
• KingTEJrBrownKKRaghuGBUILD-3: a randomized, controlled trial of bosentan in idiopathic pulmonary fibrosisAm J Respir Crit Care Med20111841929921474646
   PubMed Web of Science ®Google Scholar
• RaghuGMillion-RousseauRMorgantiAMacitentan for the treatment of idiopathic pulmonary fibrosis: the randomized controlled MUSIC trialEur Respir J20134261622163223682110
   PubMed Web of Science ®Google Scholar
• RaghuGBehrJBrownKKTreatment of idiopathic pulmonary fibrosis with ambrisentan: a parallel, randomized trialAnn Intern Med2013158964164923648946
   PubMed Web of Science ®Google Scholar
• Idiopathic Pulmonary Fibrosis Clinical Research NetworkZismanDASchwarzMAnstromKJCollardHRFlahertyKRHunninghakeGWA controlled trial of sildenafil in advanced idiopathic pulmonary fibrosisN Engl J Med2010363762062820484178
   PubMed Web of Science ®Google Scholar
• IyerSNGurujeyalakshmiGGiriSNEffects of pirfenidone on transforming growth factor-b gene expression at the transcriptional level in bleomycin hamster model of lung fibrosisJ Pharmacol Exp Ther1999291136737310490926
   PubMed Web of Science ®Google Scholar
• SpagnoloPDel GiovaneCLuppiFNon-steroid agents for idiopathic pulmonary fibrosisCochrane Database Syst Rev20109CD00313420824834
   PubMed Web of Science ®Google Scholar
• ChaudharyNIRothGJHilbergFInhibition of PDGF, VEGF and FGF signalling attenuates fibrosisEur Respir J200729597698517301095
   PubMed Web of Science ®Google Scholar
• ScottonCJKrupiczojcMAKönigshoffMIncreased local expression of coagulation factor X contributes to the fibrotic response in human and murine lung injuryJ Clin Invest200911992550256319652365
   PubMed Web of Science ®Google Scholar
• TzouvelekisAMargaritopoulosGLoukidesSBourosDWarfarin in idiopathic pulmonary fibrosis: friend or foe, is it a matter of genes and heparin?Am J Respir Crit Care Med2013187221321423322796
   PubMed Web of Science ®Google Scholar
• CantinAMHubbardRCCrystalRGGlutathione deficiency in the epithelial lining fluid of the lower respiratory tract in idiopathic pulmonary fibrosisAm Rev Respir Dis198913923703722913886
   PubMed Web of Science ®Google Scholar
• RaghuGFreudenbergerTDYangSHigh prevalence of abnormal acid gastro-oesophageal reflux in idiopathic pulmonary fibrosisEur Respir J200627113614216387946
   PubMed Web of Science ®Google Scholar
• LeeJSRyuJHElickerBMGastroesophageal reflux therapy is associated with longer survival in patients with idiopathic pulmonary fibrosisAm J Respir Crit Care Med2011184121390139421700909
   PubMed Web of Science ®Google Scholar
• LeeJSCollardHRAnstromKJAnti-acid treatment and disease progression in idiopathic pulmonary fibrosis: an analysis of data from three randomised controlled trialsLancet Respir Med20131536937624429201
   PubMed Web of Science ®Google Scholar
• TzouvelekisABourosDAnti-acid treatment for idiopathic pulmonary fibrosisLancet Respir Med20131534834924429187
   PubMed Web of Science ®Google Scholar
• SwigrisJJBrownKKThe role of endothelin-1 in the pathogenesis of idiopathic pulmonary fibrosisBio Drugs20102414954
   Google Scholar
• TzouvelekisAAntoniadisABourosDStem cell therapy in pulmonary fibrosisCurr Opin Pulm Med201117536837321681099
   PubMed Web of Science ®Google Scholar
• TzouvelekisAPaspaliarisVKoliakosGA prospective, non-randomized, no placebo-controlled, phase Ib clinical trial to study the safety of the adipose derived stromal cells-stromal vascular fraction in idiopathic pulmonary fibrosisJ Transl Med20131117123855653
   PubMed Web of Science ®Google Scholar
• TzouvelekisABourosDSteep barriers to overcome for successful application of stem cell treatment in patients with idiopathic pulmonary fibrosisAm J Respir Crit Care Med2013188225125223855695
   PubMed Web of Science ®Google Scholar
• ThabutGMalHCastierYSurvival benefit of lung transplantation for patients with idiopathic pulmonary fibrosisJ Thorac Cardiovasc Surg2003126246947512928646
   PubMed Web of Science ®Google Scholar
• GeorgeTJArnaoutakisGJShahASLung transplant in idiopathic pulmonary fibrosisArch Surg2011146101204120922006881
   PubMedGoogle Scholar
• ChristieJDEdwardsLBKucheryavayaAYThe Registry of the International Society for Heart and Lung Transplantation: Twenty-Eighth Adult Lung and Heart-Lung Transplant Report – 2011J Heart Lung Transplant201130101104112221962018
   PubMed Web of Science ®Google Scholar
• SilhanLLShahPDChambersDCLung transplantation in telomerase mutation carriers with pulmonary fibrosisEur Respir J201444117818724833766
   PubMed Web of Science ®Google Scholar
• ArizonoSTaniguchiHSakamotoKEndurance time is the most responsive exercise measurement in idiopathic pulmonary fibrosisRespir Care20145971108111524327743
   PubMedGoogle Scholar
• NishiyamaOKondohYKimuraTEffects of pulmonary rehabilitation in patients with idiopathic pulmonary fibrosisRespirology200813339439918399862
   PubMed Web of Science ®Google Scholar
• NishiyamaOTaniguchiHKondohYQuadriceps weakness is related to exercise capacity in idiopathic pulmonary fibrosisChest200512762028203315947316
   PubMed Web of Science ®Google Scholar
• EganJJFollow-up and nonpharmacological management of the idiopathic pulmonary fibrosis patientEur Respir Rev20112012011411721632799
   PubMedGoogle Scholar
• BelkinASwigrisJJHealth-related quality of life in idiopathic pulmonary fibrosis: where are we now?Curr Opin Pulm Med201319547447923851327
   PubMed Web of Science ®Google Scholar
• SwigrisJJFaircloughDLMorrisonMBenefits of pulmonary rehabilitation in idiopathic pulmonary fibrosisRespir Care201156678378921333082
   PubMed Web of Science ®Google Scholar
• DouglasWWRyuJHSchroederDRIdiopathic pulmonary fibrosis: impact of oxygen and colchicine, prednisone, or no therapy on survivalAm J Respir Crit Care Med20001614 Pt 11172117810764308
   PubMed Web of Science ®Google Scholar
• SelmanMCarrilloGEstradaAAccelerated variant of idiopathic pulmonary fibrosis: clinical behavior and gene expression patternPLoS One200725e48217534432
   PubMed Web of Science ®Google Scholar
• FlahertyKRMumfordJAMurraySPrognostic implications of physiologic and radiographic changes in idiopathic interstitial pneumoniaAm J Respir Crit Care Med2003168554354812773329
   PubMed Web of Science ®Google Scholar
• LatsiPIdu BoisRMNicholsonAGFibrotic idiopathic interstitial pneumonia: the prognostic value of longitudinal functional trendsAm J Respir Crit Care Med2003168553153712791580
   PubMed Web of Science ®Google Scholar
• du BoisRMWeyckerDAlberaCForced vital capacity in patients with idiopathic pulmonary fibrosis: test properties and minimal clinically important differenceAm J Respir Crit Care Med2011184121382138921940789
   PubMed Web of Science ®Google Scholar
• ZappalaCJLatsiPINicholsonAGMarginal decline in forced vital capacity is associated with a poor outcome in idiopathic pulmonary fibrosisEur Respir J201035483083619840957
   PubMed Web of Science ®Google Scholar
• RicheldiLRyersonCJLeeJSRelative versus absolute change in forced vital capacity in idiopathic pulmonary fibrosisThorax201267540741122426899
   PubMed Web of Science ®Google Scholar
• LeyBRyersonCJVittinghoffEA multidimensional index and staging system for idiopathic pulmonary fibrosisAnn Intern Med20121561068469122586007
   PubMed Web of Science ®Google Scholar
• WellsAUDesaiSRRubensMBIdiopathic pulmonary fibrosis: a composite physiologic index derived from disease extent observed by computed tomographyAm J Respir Crit Care Med2003167796296912663338
   PubMed Web of Science ®Google Scholar
• MuraMPorrettaMABargagliEPredicting survival in newly diagnosed idiopathic pulmonary fibrosis: a 3-year prospective studyEur Respir J201240110110922241745
   PubMed Web of Science ®Google Scholar
• SwigrisJJWamboldtFSBehrJThe 6 minute walk in idiopathic pulmonary fibrosis: longitudinal changes and minimum important differenceThorax201065217317719996335
   PubMed Web of Science ®Google Scholar
• du BoisRMWeyckerDAlberaCSix-minute-walk test in idiopathic pulmonary fibrosis: test validation and minimal clinically important differenceAm J Respir Crit Care Med201118391231123721131468
   PubMed Web of Science ®Google Scholar
• StahelRAGilksWRLehmannHPSchenkerTThird International Workshop on Lung Tumor and Differentiation Antigens: overview of the results of the central data analysisInt J Cancer Suppl199486268194898
   PubMedGoogle Scholar
• KohnoNKyoizumiSAwayaYFukuharaHYamakidoMAkiyamaMNew serum indicator of interstitial pneumonitis activity: sialylated carbohydrate antigen KL-6Chest198996168732661160
   PubMed Web of Science ®Google Scholar
• OhshimoSIshikawaNHorimasuYBaseline KL-6 predicts increased risk for acute exacerbation of idiopathic pulmonary fibrosisRespir Med201410871031103924835074
   PubMed Web of Science ®Google Scholar
• GreeneKEKingTEJrKurokiYSerum surfactant proteins-A and -D as biomarkers in idiopathic pulmonary fibrosisEur Respir J200219343944611936520
   PubMed Web of Science ®Google Scholar
• KinderBWBrownKKMcCormackFXSerum surfactant protein-A is a strong predictor of early mortality in idiopathic pulmonary fibrosisChest200913561557156319255294
   PubMed Web of Science ®Google Scholar
• TakahashiHFujishimaTKobaHSerum surfactant proteins A and D as prognostic factors in idiopathic pulmonary fibrosis and their relationship to disease extentAm J Respir Crit Care Med20001623 Pt 11109111410988138
   PubMed Web of Science ®Google Scholar
• PrasseAProbstCBargagliESerum CC-chemokine ligand 18 concentration predicts outcome in idiopathic pulmonary fibrosisAm J Respir Crit Care Med2009179871772319179488
   PubMed Web of Science ®Google Scholar
• ZuoFKaminskiNEuguiEGene expression analysis reveals matrilysin as a key regulator of pulmonary fibrosis in mice and humansProc Natl Acad Sci U S A20029996292629711983918
   PubMed Web of Science ®Google Scholar
• RosasIORichardsTJKonishiKMMP1 and MMP7 as potential peripheral blood biomarkers in idiopathic pulmonary fibrosisPLoS Med20085e9318447576
   PubMed Web of Science ®Google Scholar
• Herazo-MayaJDNothIDuncanSRPeripheral blood mononuclear cell gene expression profiles predict poor outcome in idiopathic pulmonary fibrosisSci Transl Med20135205205r a136.
   Web of Science ®Google Scholar
• SongJWDoKHJangSJColbyTVHanSKimDSBlood biomarkers MMP-7 and SP-A: predictors of outcome in idiopathic pulmonary fibrosisChest201314351422142923715088
   PubMed Web of Science ®Google Scholar
• SpagnoloPSverzellatiNRossiGIdiopathic pulmonary fibrosis: an updateAnn Med1222015 [Epub ahead of print]
   PubMed Web of Science ®Google Scholar
• BourosDTzouvelekisAIdiopathic pulmonary fibrosis: on the moveLancet Respir Med201421171924461889
   PubMed Web of Science ®Google Scholar